Literature DB >> 27143256

CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Julia E Maxson1, Rhonda E Ries1, Yi-Cheng Wang2, Robert B Gerbing2, E Anders Kolb3, Sarah L Thompson1, Jaime M Guidry Auvil4, Marco A Marra5, Yussanne Ma5, Zusheng Zong5, Andrew J Mungall5, Richard Moore5, William Long5, Patee Gesuwan4, Tanja M Davidsen4, Leandro C Hermida4, Seamus B Hughes1, Jason E Farrar6, Jerald P Radich1, Malcolm A Smith7, Daniela S Gerhard4, Alan S Gamis8, Todd A Alonzo9, Soheil Meshinchi10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27143256      PMCID： PMC4911865          DOI： 10.1182/blood-2016-04-709899

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  23 in total

1.  G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

Authors:  Muneyoshi Futami; Quan-Sheng Zhu; Zakary L Whichard; Ling Xia; Yuehai Ke; Benjamin G Neel; Gen-Sheng Feng; Seth J Corey
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia.

Authors:  Renée Beekman; Marijke Valkhof; Paulette van Strien; Peter J M Valk; Ivo P Touw
Journal:  Haematologica       Date:  2013-03-18       Impact factor: 9.941

3.  CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8; 21).

Authors:  Hitoshi Sano; Kentaro Ohki; Myoung-Ja Park; Norio Shiba; Yusuke Hara; Manabu Sotomatsu; Daisuke Tomizawa; Takashi Taga; Nobutaka Kiyokawa; Akio Tawa; Keizo Horibe; Souichi Adachi; Yasuhide Hayashi
Journal:  Br J Haematol       Date:  2015-04-09       Impact factor: 6.998

4.  Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor.

Authors:  S J Corey; P M Dombrosky-Ferlan; S Zuo; E Krohn; A D Donnenberg; P Zorich; G Romero; M Takata; T Kurosaki
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

5.  Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.

Authors:  Adrian F Gombart; Wolf-K Hofmann; Seiji Kawano; Seisho Takeuchi; Utz Krug; Scott H Kwok; Renee J Larsen; Hiroya Asou; Carl W Miller; Dieter Hoelzer; H Phillip Koeffler
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

6.  Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases.

Authors:  S J Corey; A L Burkhardt; J B Bolen; R L Geahlen; L S Tkatch; D J Tweardy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.

Authors:  A C Ward; Y M van Aesch; A M Schelen; I P Touw
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

8.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528

Review 9.  The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.

Authors:  Jason Gotlib; Julia E Maxson; Tracy I George; Jeffrey W Tyner
Journal:  Blood       Date:  2013-07-29       Impact factor: 22.113

10.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.

Authors:  G J Lieschke; D Grail; G Hodgson; D Metcalf; E Stanley; C Cheers; K J Fowler; S Basu; Y F Zhan; A R Dunn
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113
View more
  16 in total

1.  A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.

Authors:  Yaling Qiu; Yangyang Zhang; Nan Hu; Fan Dong
Journal:  J Biol Chem       Date:  2017-01-10       Impact factor: 5.157

2.  The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Authors:  Hamid Bolouri; Jason E Farrar; Timothy Triche; Rhonda E Ries; Emilia L Lim; Todd A Alonzo; Yussanne Ma; Richard Moore; Andrew J Mungall; Marco A Marra; Jinghui Zhang; Xiaotu Ma; Yu Liu; Yanling Liu; Jaime M Guidry Auvil; Tanja M Davidsen; Patee Gesuwan; Leandro C Hermida; Bodour Salhia; Stephen Capone; Giridharan Ramsingh; Christian Michel Zwaan; Sanne Noort; Stephen R Piccolo; E Anders Kolb; Alan S Gamis; Malcolm A Smith; Daniela S Gerhard; Soheil Meshinchi
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

Review 3.  Genomics of chronic neutrophilic leukemia.

Authors:  Julia E Maxson; Jeffrey W Tyner
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

Review 4.  C/EBPα deregulation as a paradigm for leukemogenesis.

Authors:  J A Pulikkan; D G Tenen; G Behre
Journal:  Leukemia       Date:  2017-07-19       Impact factor: 11.528

5.  Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia.

Authors:  Katherine Tarlock; Todd Alonzo; Yi-Cheng Wang; Robert B Gerbing; Rhonda E Ries; Tiffany Hylkema; Jenny L Smith; Julia E Maxson; Soheil Meshinchi
Journal:  Blood       Date:  2020-04-30       Impact factor: 22.113

6.  A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia.

Authors:  David R Spiciarich; Stephen T Oh; Amy Foley; Seamus B Hughes; Michael J Mauro; Omar Abdel-Wahab; Richard D Press; Rosa Viner; Sarah L Thompson; Qiushi Chen; Parastoo Azadi; Carolyn R Bertozzi; Julia E Maxson
Journal:  Cancer Res       Date:  2018-10-22       Impact factor: 12.701

7.  Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.

Authors:  Theodore P Braun; Cody Coblentz; Brittany M Curtiss; Daniel J Coleman; Zachary Schonrock; Sarah A Carratt; Rowan L Callahan; Breanna Maniaci; Brian J Druker; Julia E Maxson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-29       Impact factor: 11.205

8.  CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.

Authors:  Katherine Tarlock; Adam J Lamble; Yi-Cheng Wang; Robert B Gerbing; Rhonda E Ries; Michael R Loken; Lisa Eidenschink Brodersen; Laura Pardo; Amanda Leonti; Jenny L Smith; Tiffany A Hylkema; William G Woods; Todd M Cooper; E Anders Kolb; Alan S Gamis; Richard Aplenc; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2021-09-30       Impact factor: 25.476

Review 9.  Acute Myeloid Leukemia: Advancements in Diagnosis and Treatment.

Authors:  Meng-Ge Yu; Hu-Yong Zheng
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

10.  Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.

Authors:  H Zhang; A Reister Schultz; S Luty; A Rofelty; Y Su; S Means; D Bottomly; B Wilmot; S K McWeeney; J W Tyner
Journal:  Leukemia       Date:  2017-04-25       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.